However, up to 90% of patients with polycythemia vera have a homozygous mutation of a single amino acid in JAK2. In these cases, the valine is replaced by phenylalanine in the amino acid 617, which makes the enzyme constitutively active. The gene discussed is JAK2; the disease is acquired polycythemia vera.